Bottom line is; Several other countries patent office “ran a ruler over this IP” & it measures up. Some investors could say; 3 balls hit out of the park! Hence, as far as international observers are concerned AXE has a professional approach & ticking most boxes.
Watching many other companies on ASX apply for patents is like watching wet paint dry. The rules are there for a reason & hence it is as if AFR reporter seeks to learn more about “trade secrets” or intellectual property not available to investors or competitors, let alone the market. Nice try for the big news story ?
Bad news stories are good for media as they generate more income! Looking on the bright side the questions asked in media & ASX is generating free media coverage and could attract more future investors.
No finance advice intended or disrespect for media. It is a long road ahead for AXE’s commercial success and we might expect more media attention in due time.
- Forums
- ASX - By Stock
- Ann: Response to ASX Query
AXE
archer materials limited
Add to My Watchlist
0.00%
!
23.0¢

Bottom line is; Several other countries patent office “ran a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $89.25K | 387.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 56023 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 0.230 |
8 | 182195 | 0.225 |
11 | 234057 | 0.220 |
7 | 58193 | 0.215 |
8 | 164657 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 4141 | 1 |
0.240 | 101099 | 4 |
0.245 | 7000 | 1 |
0.250 | 76000 | 3 |
0.255 | 129000 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online